The Latest on Melanoma and Treatment - Part 4: Advances in Immune Therapy

Jeff Infante, M.D.

The Latest on Melanoma and Treatment - Part 4: Advances in Immune Therapy

Jeff Infante, M.D., Director of Drug Development Unit at Sarah Cannon Research Institute and Medical Oncologist at Tennessee Oncology, provides the latest update in developing immunotherapies to treat melanoma. The immotherapies now are allowing the immune system to recognize the cancerous cells and for the immune system to fight the cancer itself. Improvements have also been made in greater tolerance for side effects of the immotherapy for melanoma.